Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5631-5639

  Seidl, Kati ^a,d   Chen, Liang ^b   Bayer, Arnold S ^a,c   Hady, Wessam Abdel ^a   Kreiswirth, Barry N ^b   Xiong, Yan Q ^a,c  

^a UCLA MEDICAL CENTER   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOLYSIN; VANCOMYCIN;

ACCESSORY GENE REGULATOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; GENE LOCUS; GENE SEQUENCE; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, REGULATOR; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; RABBITS; STAPHYLOCOCCAL INFECTIONS; TRANS-ACTIVATORS; TREATMENT OUTCOME; VANCOMYCIN; VIRULENCE;

EID: 81555206708     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05251-11     Document Type: Article

References (53)

1. Abdelnour, A., S. Arvidson, T. Bremell, C. Ryden, and A. Tarkowski. 1993. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model. Infect. Immun. 61:3879-3885. (Pubitemid 23260062)
2. Chang, F. Y., et al. 2003. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 82:322-332.
3. Cheung, A. L., et al. 1994. Diminished virulence of a sar/agr mutant of Staphylococcus aureus in the rabbit model of endocarditis. J. Clin. Invest. 94:1815-1822.
4. CLSI. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 8th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Dhawan, V. K., M. R. Yeaman, and A. S. Bayer. 1999. Influence of in vitro susceptibility phenotype against thrombin-induced platelet microbicidal protein on treatment and prophylaxis outcomes of experimental Staphylococcus aureus endocarditis. J. Infect. Dis. 180:1561-1568. (Pubitemid 29506458)
6. Drugeon, H., M. Juvin, J. Pirault, and P. Dellamonica. 1988. Bactericidal activity of pefloxacin in combination with rifampicin, fosfomycin and vancomycin against Staphylococcus aureus: determination by a dynamic method. Rev. Infect. Dis. 10:80-81.
7. Fowler, V. G., Jr., et al. 2006. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355:653-665.
8. Fowler, V. G., Jr., et al. 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293:3012-3021.
9. Fowler, V. G., Jr., et al. 2004. Persistent bacteremia due to methicillinresistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190:1140-1149.
10. Fowler, V. G., et al. 2007. Potential associations between hematogenous complications and bacterial genotype in Staphylococcus aureus infection. J. Infect. Dis. 196:738-747.
11. Fusco, D. N., et al. 2009. Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus. Diagn. Microbiol. Infect. Dis. 65:180-183.
12. Gillaspy, A. F., et al. 1995. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect. Immun. 63:3373-3380.
13. Goerke, C., et al. 2000. Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro. Infect. Immun. 68:1304-1311. (Pubitemid 30108526)
14. Grundmann, H., M. Aires-de-Sousa, J. Boyce, and E. Tiemersma. 2006. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368:874-885. (Pubitemid 44308640)
15. Hardy, K. J., P. M. Hawkey, F. Gao, and B. A. Oppenheim. 2004. Methicillin resistant Staphylococcus aureus in the critically ill. Br. J. Anaesth. 92:121-130. (Pubitemid 38054659)
16. Hoen, B., et al. 2002. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288:75-81. (Pubitemid 34705521)
17. B modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J. Bacteriol. 184:5457-5467.
18. Jarraud, S., et al. 2000. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 182:6517-6522.
19. Ji, G., R. Beavis, and R. P. Novick. 1997. Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030. (Pubitemid 27443604)
20. Khatib, R., et al. 2006. Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome. Scand. J. Infect. Dis. 38:7-14. (Pubitemid 43123837)
21. Kielian, T., A. Cheung, and W. F. Hickey. 2001. Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect. Immun. 69:6902-6911. (Pubitemid 32995450)
22. Kong, K. F., C. Vuong, and M. Otto. 2006. Staphylococcus quorum sensing in biofilm formation and infection. Int. J. Med. Microbiol. 296:133-139. (Pubitemid 43375996)
23. Kuroda, M., et al. 2001. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 357:1225-1240. (Pubitemid 32539050)
24. McCalla, C., et al. 2008. Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob. Agents Chemother. 52:3441-3443.
25. McElroy, J., M. Nelson, S. Caillier, and J. Oksenberg. 2009. Copy number variation in African Americans. BMC Genet. 10:15.
26. McNamara, P. J., and A. S. Bayer. 2005. A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditis. Infect. Immun. 73:3806-3809. (Pubitemid 40745933)
27. Moise, P. A., et al. 2010. Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bac- teremia: role of platelet microbicidal protein killing and agr genotypes. J. Infect. Dis. 201:233-240.
28. Moise, P. A., A. Forrest, M. Birmingham, and J. J. Schentag. 2002. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have feiled to respond to, vancomycin. J. Antimicrob. Chemother. 50:1017-1026. (Pubitemid 36032826)
29. Moise, P. A., and J. J. Schentag. 2000. Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections. Int. J. Antimicrob. Agents 16:S31-S34. (Pubitemid 32007934)
30. Moise, P. A., et al. 2009. Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies. J. Antimicrob. Chemother. 63:873-876.
31. Moise-Broder, P. A., et al. 2004. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38:1700-1705. (Pubitemid 38781661)
32. Mwangi, M. M., et al. 2007. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U. S. A. 104:9451-9456. (Pubitemid 47185800)
33. Novick, R., et al. 1993. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12:3967-3975. (Pubitemid 23282772)
34. Novick, R. P., and E. Geisinger. 2008. Quorum sensing in staphylococci. Annu. Rev. Genet. 42:541-564.
35. Recsei, P., et al. 1986. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol. Gen. Genet. 202:58-61. (Pubitemid 16150393)
36. Robinson, D. A., A. B. Monk, J. E. Cooper, E. J. Feil, and M. C. Enright. 2005. Evolutionary genetics of the accessory gene regulator (agr) locus in Staphylococcus aureus. J. Bacteriol. 187:8312-8321. (Pubitemid 41780495)
37. Sakoulas, G., et al. 2003. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediatelevel glycopeptide resistance? J. Infect. Dis. 187:929-938.
38. Sakoulas, G., et al. 2006. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J. Antimicrob. Chemother. 57:699-704.
39. Schwan, W. R., M. H. Langhorne, H. D. Ritchie, and C. K. Stover. 2003. Loss of hemolysin expression in Staphylococcus aureus agr mutants correlates with selective survival during mixed infections in murine abscesses and wounds. FEMS Immunol. Med. Microbiol. 38:23-28. (Pubitemid 37297439)
40. Seidl, K., et al. 2011. Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates. Antimicrob. Agents Chemother. 55:575-582.
41. Seidl, K., et al. 2006. Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob. Agents Chemother. 50:1183-1194.
42. Traber, K., and R. Novick. 2006. A slipped-mispairing mutation in AgrA of laboratory strains and clinical isolates results in delayed activation of agr and failure to translate δ- and α-haemolysins. Mol. Microbiol. 59:1519-1530.
43. Traber, K. E., et al. 2008. agr function in clinical Staphylococcus aureus isolates. Microbiology 154:2265-2274.
44. van Leeuwen, W., W. van Nieuwenhuizen, C. Gijzen, H. Verbrugh, and A. van Belkum. 2000. Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agrD gene, encoding a staphylococcal autoinducer peptide. J. Bacteriol. 182:5721-5729.
45. Van Wamel, W. J., G. van Rossum, J. Verhoef, C. M. Vandenbroucke-Grauls, and A. C. Fluit. 1998. Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis. FEMS Microbiol. Lett. 163:1-9.
46. Wisplinghoff, H., et al. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317. (Pubitemid 39050477)
47. Wong, Y. W., J. Chew, H. Yang, D. T. H. Tan, and R. Beuerman. 2006. Expression of insulin-like growth factor binding protein-3 in pterygium tissue. Br. J. Ophthalmol. 90:769-772. (Pubitemid 43835499)
48. Wootton, M., et al. 2001. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J. Antimicrob. Chemother. 47:399-403. (Pubitemid 32303403)
49. Wright, J. S., et al. 2005. The agr radiation: an early event in the evolution of staphylococci. J. Bacteriol. 187:5585-5594.
50. Wright, J. S., R. Jin, and R. P. Novick. 2005. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc. Natl. Acad. Sci. U. S. A. 102:1691-1696. (Pubitemid 40209229)
51. Xiong, Y. Q., et al. 2009. Phenotypic and genotypic characteristics of persistent methicillin-resistant Staphylococcus aureus bacteremia in vitro and in an experimental endocarditis model. J. Infect. Dis. 199:201-208.
52. Yarwood, J. M., J. K. McCormick, M. L. Paustian, V. Kapur, and P. M. Schlievert. 2002. Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. J. Bacteriol. 184:1095-1101. (Pubitemid 34113378)
53. Zannoni, A., et al. 2007. Prostaglandin F2-alpha receptor (FPr) expression on porcine corpus luteum microvascular endothelial cells (pCL-MVECs). Reprod. Biol. Endocrinol. 5:31